News & Events

  • Antibody Industrial Symposium 2017

    ImmunXperts will be present at the 5th Antibody Industrial Symposium 2017 in held in Tours, France on 27- 28 Jun 2017. AIS2017 will focus on Antibody-Drug Conjugates: Design & Development for Therapy and Imaging in and beyond Cancer. www.ais2017.fr

  • SMi Immunogenicity 2017

    Sofie Pattijn will be presenting at SMi’s 4th annual Immunogenicity conference on the unwanted immunogenicity of immuno-oncology drugs. The conference is held from 12th June to 13th June 2017 in London, United Kingdom. SMi Immunogenicity

  • Knowledge for Growth 2017

    ImmunXperts is presenting a poster on “The Use of In Vitro Assays to Accelerate Cancer Immunotherapy Development” at the Knowledge for Growth conference, held on May 18, 2017 in Ghent, Belgium . Meet Sofie Pattijn and Thibault Jonckheere at poster number 57. www.knowledgeforgrowth.be  

  • Advances in Immuno-oncology Congress 2017

    ImmunXperts will be presenting at Oxford Global 2nd Advances in Immuno-oncology Congress in London, May 15-16th. Meet Sofie Pattijn during her presentation or at our poster on In vitro Functional Assays to accelerate immuno-oncology drug design. http://www.immunooncology-congress.com

  • PEGS Boston 2017

    Meet ImmunXperts at the 13th Annual PEGSummit in Boston, MA (May 1-5, 2017). Sofie Pattijn will be presenting a poster, titled: “In Vitro Functional Bioassays of Candidate Therapeutics in Immuno-Oncology”. http://www.pegsummit.com

  • ICI Boston 2017

    ImmunXperts will be presenting a poster on our immuno-oncology services at the 3rd Annual ICI Boston conference, held from March 14-16, 2017 in Boston. http://immune-checkpoint.com/

  • ImmunXperts Announces New Collaboration and Biowin Grant Award

    Gosselies, Belgium – October 24, 2016 — ImmunXperts S.A, together with Iteos Therapeutics S.A., ChemCom S.A., the de Duve Institute and IRIBHM have been awarded 1,6 million euro grant through a BioWin project called IT-Targets. The aim of this collaboration is to identify innovative drug candidates and biomarkers for immunotherapy of various types of cancer, […]

  • BioJapan 2016

    ImmunXperts will be present this week on the 18th BioJapan event, held from 12 to 14 Oct. 2016 in Yokohama, Japan. We are happy to meet you if you are around! www.ics-expo.jp/biojapan

  • PEGS Summit Korea 2016

    This week ImmunXperts will be in South Korea at the 2nd Annual PEGS Summit Korea held from 20-22 Sept in Seoul. Sofie Pattijn will be talking on the use of in vitro assays in the development of cancer immunotherapies. With the new wave of candidate cancer therapies acting mainly on the immune system via immune checkpoint […]

  • ImmunXperts to increase capital and appoint Thibault Jonckheere as CEO

    Gosselies, September 16th 2016 – ImmunXperts SA today announced that Thibault Jonckheere joined the fast growing company as CEO. Simultaneously, the immunogenicity company increased its capital to further accelerate the development of its immuno-oncology and cell therapy services. “ImmunXperts supports its partners in the evaluation of new drug candidates with a solid experimental platform for […]

  • Bioregate Forum 2016

    ImmunXperts will be present on the first edition of Bioregate Forum 2016 from 8-9 Sept in Nantes, France. http://www.bioregate-forum.com/